However, most people get infected with TB don’t get sick, according to NCDHSS. That’s because their bodies can fight the germs, a condition known as latent TB infection (LTBI). People with LTBI cannot ...

A new study, "Identifying Allosteric Hotspots in Mycobacterium tuberculosis cAMP Receptor Protein" published in Biochemistry, provides key insights into how bacterial cAMP receptor proteins (CRPs) ...

Early detection and treatment plans have helped limit further disease transmission in the US. However, we've seen numbers ...

A new study published in Biochemistry sheds light on how bacteria regulate their genes, challenging long-held assumptions ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough, ...

A new study led by Dr. Rodrigo Maillard at Georgetown University, “Identifying Allosteric Hotspots in Mycobacterium tuberculosis cAMP Receptor Protein through Structural Homology,” published in ...

Jan. 29, 2025 — Study finds three new safe and effective drug regimens to fight multidrug-resistant TB. The treatments, which include recently discovered TB drugs, give new options for shorter ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

While TB cases have been rising nationally in recent years, public health officials continue to emphasize there is no threat ...

As Kansas deals with one of the largest tuberculous outbreaks in the nation since the 1950s, Californians may be wondering ...

Bacille Calmette-Guérin (BCG) is the vaccine for tuberculosis, but according to Collins, it is not routinely given in the U.S. According to the CDC, this is due to several reasons, including the mixed ...

As one of the largest tuberculosis outbreaks in the U.S. unfolds in Kansas, UC San Diego researchers and their colleagues ...